Company Telomir Pharmaceuticals, Inc.

TELO

US87975F1049

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 28/05/2024 BST			5-day change	1st Jan Change
6.23 ^USD	-7.57%		+3.15%	0.00%

05-13	Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C	CI

Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acidâs (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.

Number of employees: 5

Managers	Title	Age	Since
Christopher Chapman CEO	Chief Executive Officer	71	25/08/21
Nathen Fuentes DFI	Director of Finance/CFO	41	20/09/23
Michelle Yanez AUD	Comptroller/Controller/Auditor	52	30/04/22

Members of the board	Title	Age	Since
Christopher Chapman CEO	Chief Executive Officer	71	25/08/21
Craig Eagle BRD	Director/Board Member	57	31/10/22
Talhia Tuck BRD	Director/Board Member	46	31/10/22
Brad Kroenig BRD	Director/Board Member	45	31/10/22
Hugh McColl BRD	Director/Board Member	63	31/10/22
Michelle Yanez AUD	Comptroller/Controller/Auditor	52	30/04/22
Michael Jerman BRD	Director/Board Member	40	10-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	29,609,814	17,031,576 ( 57.52 %)	0	57.52 %

Name	Equities	%	Valuation
Brian McNulty 29.54 %	8,748,126	29.54 %	59 M $
Donnell Francis E Jr O 7.157 %	2,119,220	7.157 %	14 M $
Christopher Chapman 3.295 %	975,610	3.295 %	7 M $
Craig Eagle 1.647 %	487,805	1.647 %	3 M $
Nathen Fuentes 0.3416 %	101,134	0.3416 %	687 711 $
Talhia Tuck 0.1647 %	48,781	0.1647 %	331 711 $
Brad Kroenig 0.1647 %	48,781	0.1647 %	331 711 $
Hugh McColl 0.1647 %	48,781	0.1647 %	331 711 $
Suncoast Equity Management LLC 0.0824 %	24,391	0.0824 %	165 859 $
Citigroup Global Markets, Inc. (Investment Management) 0.0599 %	17,748	0.0599 %	120 686 $

Telomir Pharmaceuticals, Inc.

855 North Wolfe Street Suite 601

21205, Baltimore

http://www.telomirpharma.com

address Telomir Pharmaceuticals, Inc.(TELO)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
TELOMIR PHARMACEUTICALS, INC.	0.00%	200M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.66%	328B
ABBVIE INC.	+0.24%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.23%	164B
PFIZER, INC.	-1.70%	164B